Relapsed/refractory IgG4-related disease (R/R IgG4-RD)

Clinical trials for Relapsed/refractory IgG4-related disease (R/R IgG4-RD) explained in plain language.

Never miss a new study

Get alerted when new Relapsed/refractory IgG4-related disease (R/R IgG4-RD) trials appear

Sign up with your email to follow new studies for Relapsed/refractory IgG4-related disease (R/R IgG4-RD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New gene therapy trial targets tough autoimmune conditions

Disease control Not yet recruiting

This early-stage study tests a new treatment called LVIVO-TaVec400 in 44 people with severe autoimmune diseases like lupus, multiple sclerosis, and myasthenia gravis that have not responded to standard therapies. The main goals are to check the treatment's safety and find the rig…

Matched conditions: RELAPSED/REFRACTORY IGG4-RELATED DISEASE (R/R IGG4-RD)

Early phase 1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control

Last updated Jun 27, 2026 12:33 UTC

Relapsed/refractory IgG4-related disease (R/R IgG4-RD)

Get alerted when new Relapsed/refractory IgG4-related disease (R/R IgG4-RD) trials appear

New gene therapy trial targets tough autoimmune conditions